Articles

World apheresis registry data from 2003 to 2007, the pediatric and adolescent side of the registry.

Witt V, Stegmayr B, Ptak J, Wikström B, Berlin G, Axelsson CG, Griskevicius A, Centoni PE, Liumbruno GM, Molfettini P, Audzijoniene J, Mokvist K, Sojka BN, Norda R, Ramlow W, Blaha M, Evergren M, Tomaz J.

Transfus Apher Sci. 2008 Dec;39(3):255-60. Epub 2008 Nov 14.

Recognition of intercenter differences may help develop best practice.

Norda R, Axelsson CG, Axdorph U, Berlin G, Wikström B, Stegmayr B; Swedish Apheresis Group.

Ther Apher Dial. 2008 Oct;12(5):347-54.

World apheresis registry 2003-2007 data.

Stegmayr B, Ptak J, Wikström B, Berlin G, Axelsson CG, Griskevicius A, Centoni P, Liumbruno G, Molfettini P, Audzijoniene J, Mokvist K, Sojka BN, Norda R, Knutson F, Ramlow W, Blaha M, Witt V, Evergren M, Tomaz J.

Transfus Apher Sci. 2008 Dec;39(3):247-54. Epub 2008 Oct 31.

World apheresis registry report.

Stegmayr B, Ptak J, Wikström B.

Transfus Apher Sci. 2007 Feb;36(1):13-6. Epub 2007 Jan 17.

World apheresis association--world apheresis registry.

Stegmayr BG, Ivanovich P, Korach JM, Rock G, Norda R, Ramlow W.

Transfus Apher Sci. 2005 Apr;32(2):205-7.

Therapeutic apheresis in Sweden: update of epidemiology and adverse events.

Norda R, Stegmayr BG; Swedish Apheresis Group.

Transfus Apher Sci. 2003 Oct;29(2):159-66.

Adverse events and problems in therapeutic hemapheresis. A report from the Swedish registry.

Norda R, Berséus O, Stegmayr B.

Transfus Apher Sci. 2001 Aug;25(1):33-41.

Apheresis registry in Sweden: scope, techniques and indications for treatment. A report from the Swedish apheresis study group.

Norda R, Stegmayr BG; Swedish Apheresis Study Group.

Transfus Apher Sci. 2001 Feb;24(1):49-55.

Posters

Therapeutic apheresis in Sweden: Update of epidemiology and adverse events.
Norda R, Stegmayr B, Group SA.
ESFH congress; 2003 September; Prag.

Therapeutic apheresis in Sweden: Update of epidemiology and adverse events.
Norda R, Stegmayr B, group SA.
ISFA congress; 2003 Oct. 2003; Nashville; 2003. p. A14-A15.

Analyses of adverse events during apheresis with focus on substitution fluid. The Swedish registry.
Norda R, Axdorph U, Axelsson C-G, Berlin G, Jonsson S, Kumlien G, et al.
World Apheresis Association(WAA) and American Society For Apheresis (ASFA). May, 2004; Miami, USA.

Plasma exchange: current practices in Sweden and the role of substitution fluids in patterns of adverse effects.
Norda R, Axelsson C-G, Stegmayr BG, Swedish Apheresis Group.
ISFA congress; 2005; Rostock, Germany.

World apheresis registry report of 2004 data.
Stegmayr BG, Ptak J, Wikström B, Berlin G, Axelsson C-G, Griskevicius A, et al.
ISFA Congress; 2005; Rostock, Germany.

Terapeutisk hemaferes – skillnader mellan behandlingsenheter kan vara till hjälp I förbättringsarbetet.
Norda R, Axelsson CG, Axdorph U, Berlin G, Kurkus J, Stegmyer B, Wikström B.  
Svenska kvalitetsregisterdagarna Linköping; oktober 2006.

World apheresis registry 2005 data.
Stegmayr BG, Ptak J, Wikstrom B, et al.
European Society For Apheresis, June 20-21, 2006., edited by B.G. S, Umea, Sweden.

World apheresis registry - The new interventional version.
Stegmayr B4, Ptak J3, Wikström B5, Berlin G6, Axelsson CG7, Griskevicius A1, Centoni P2, Liumbruno G2, Molfettini P2, Audzijoniene J1, Mokvist K5, Nilsson Sojka B1, Norda R 12,  Ramlow W10, Blaha M8, Witt V9, Evergren M10,  Tomaz J11  Vilnius, Lithuania1, Livorno, Italy2, Ostrava, Czech Republic3, Umea4, Uppsala5, Linkoping6, Orebro7, Huddinge10, Sweden7. Rostock, Germany10, Hradec Kralove, Czech Republic8, Vienna, Austria9
Coimbra, Portugal.
ESFH congress, Dusseldorf, Germany, October 2008.